Showing 1,101 - 1,120 results of 106,262 for search '(( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 12 mean decrease ))', query time: 1.58s Refine Results
  1. 1101

    Hydrolysis Stability of Bidentate Phosphites Utilized as Modifying Ligands in the Rh-Catalyzed <i>n</i>‑Regioselective Hydroformylation of Olefins by Baoxin Zhang (1570096)

    Published 2016
    “…Electron-withdrawing groups in the periphery of the acylphosphite moiety decrease the stability of <b>L1</b>, whereas 3,5-disubstituted salicylic acid derivatives with bulky groups showed superior stability. …”
  2. 1102

    Hydrolysis Stability of Bidentate Phosphites Utilized as Modifying Ligands in the Rh-Catalyzed <i>n</i>‑Regioselective Hydroformylation of Olefins by Baoxin Zhang (1570096)

    Published 2016
    “…Electron-withdrawing groups in the periphery of the acylphosphite moiety decrease the stability of <b>L1</b>, whereas 3,5-disubstituted salicylic acid derivatives with bulky groups showed superior stability. …”
  3. 1103

    Hydrolysis Stability of Bidentate Phosphites Utilized as Modifying Ligands in the Rh-Catalyzed <i>n</i>‑Regioselective Hydroformylation of Olefins by Baoxin Zhang (1570096)

    Published 2016
    “…Electron-withdrawing groups in the periphery of the acylphosphite moiety decrease the stability of <b>L1</b>, whereas 3,5-disubstituted salicylic acid derivatives with bulky groups showed superior stability. …”
  4. 1104
  5. 1105
  6. 1106

    Rab7A decreases BST2 cell surface expression and is required for Vpu-induced BST2 cell surface downregulation. by Marina Caillet (198168)

    Published 2011
    “…<p>(<b>A</b>–<b>B</b>) Rab7A decreases BST2 cell surface expression. …”
  7. 1107
  8. 1108
  9. 1109

    A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes by Sharon Cresci (53599)

    Published 2010
    “…Consistent with previous descriptions of PPARα in experimental models and human disease, we describe a novel <em>PPARA</em> promoter SNP that decreases transcriptional activation of <em>PPARA</em> and protects against mortality in diabetic patients after ACS.…”
  10. 1110
  11. 1111
  12. 1112
  13. 1113
  14. 1114
  15. 1115
  16. 1116
  17. 1117
  18. 1118
  19. 1119
  20. 1120